Open AccessBenefits and harm of systemic steroids for short‐ and long‐term use in rhinitis and rhinosinusitis: an EAACI position paper
Author(s) -
Hox Valerie,
Lourijsen Evelijn,
Jordens Arnout,
Aasbjerg Kristian,
Agache Ioana,
Alobid Isam,
Bachert Claus,
Boussery Koen,
Campo Paloma,
Fokkens Wytske,
Hellings Peter,
Hopkins Claire,
Klimek Ludger,
Mäkelä Mika,
Mösges Ralph,
Mullol Joaquim,
Pujols Laura,
Rondon Carmen,
Rudenko Michael,
ToppilaSalmi Sanna,
Scadding Glenis,
Scheire Sophie,
Tomazic PeterValentin,
Van Zele Thibaut,
Wagenmann Martin,
Boven Job F. M.,
Gevaert Philippe
Publication year - 2020
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/s13601-019-0303-6
Subject(s) - medicine , rhinology , intensive care medicine , chronic rhinosinusitis , position paper , airway , allergy , dermatology , immunology , otorhinolaryngology , surgery , pathology
Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that—potentially severe—side‐effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.